The protective role of carnosic acid against beta-amyloid toxicity in rats

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Rasoolijazi, H ^a,b   Azad, N ^c   Joghataei, M T ^a,b   Kerdari, M ^b   Nikbakht, F ^b   Soleimani, M ^a,b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ABIETANE DERIVATIVE; AMYLOID BETA PROTEIN; PLANT EXTRACT; SALVIN;

ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; MALE; MAZE TEST; RAT; WISTAR RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; AVOIDANCE LEARNING; DITERPENES, ABIETANE; MALE; MAZE LEARNING; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84893839308     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/917082     Document Type: Article

References (27)

1. Kar S., Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology. Drug Development Research 2002 56 2 248 263 2-s2.0-0036592957 10.1002/ddr.10080 (Pubitemid 35014947)
2. Parihar M. S., Hemnani T., Alzheimer's disease pathogenesis and therapeutic interventions. Journal of Clinical Neuroscience 2004 11 5 456 467 2-s2.0-3042833662 10.1016/j.jocn.2003.12.007 (Pubitemid 38869470)
3. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P. V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A. I., Lah J. J., Variant of TREM2 associated with the risk of Alzheimer's disease. The New England Journal of Medicine 2013 368 107 116
4. Salloway S., Mintzer J., Weiner M. F., Cummings J. L., Disease-modifying therapies in Alzheimer's disease. Alzheimer's and Dementia 2008 4 2 65 79 2-s2.0-40749160944 10.1016/j.jalz.2007.10.001 (Pubitemid 351384361)
5. Kehoe P. G., Angiotensins and Alzheimer's disease: a bench to bedside overview. Alzheimer's Research & Therapy 2009 1 1 8
6. Clippingdale A. B., Wade J. D., Barrow C. J., The amyloid- β peptide and its role in Alzheimer's disease. Journal of Peptide Science 2001 7 5 227 249 2-s2.0-0034961205 10.1002/psc.324 (Pubitemid 32586583)
7. Praticò D., Clark C. M., Liun F., Lee V. Y.-M., Trojanowski J. Q., Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Archives of Neurology 2002 59 6 972 976 2-s2.0-0036284936 (Pubitemid 34640757)
8. Gilgun-Sherki Y., Melamed E., Offen D., Antioxidant treatment in Alzheimer's disease: current state. Journal of Molecular Neuroscience 2003 21 1 1 11 2-s2.0-0141673405 10.1385/JMN:21:1:1 (Pubitemid 37204866)
9. Shabtay A., Sharabani H., Barvish Z., Kafka M., Amichay D., Levy J., Sharoni Y., Uskokovic M. R., Studzinski G. P., Danilenko M., Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncology 2008 75 3-4 203 214 2-s2.0-53549116450 10.1159/000163849
10. Munné-Bosch S., Alegre L., Subcellular compartmentation of the diterpene carnosic acid and its derivatives in the leaves of rosemary. Plant Physiology 2001 125 2 1094 1102 2-s2.0-0035115575 10.1104/pp.125.2.1094 (Pubitemid 32169914)
11. Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y., Kitajima C., Cui J., Kamins J., Okamoto S.-I., Izumi M., Shirasawa T., Lipton S. A., Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. Journal of Neurochemistry 2008 104 4 1116 1131 2-s2.0-38449111059 10.1111/j.1471-4159.2007.05039.x (Pubitemid 351143643)
12. Azad N., Rasoolijazi H., Joghataie M. T., Soleimani S., Neuroprotective effects of carnosic acid in an experimental model of Alzheimer's disease in rats. Cell Journal 2011 13 1 39 44 2-s2.0-80054698236
13. Silva R. H., Felicio L. F., Frussa-Filho R., Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice. Psychopharmacology 1999 141 2 111 117 2-s2.0-0032925298 10.1007/s002130050814 (Pubitemid 29200161)
14. He J., Chen Y.-M., Wang J.-H., Ma Y.-Y., Effect of Co-administration of morphine and cholinergic antagonists on Y-maze spatial recognition memory retrieval and locomotor activity in mice. Zoological Research 2008 6 613 620
15. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., Furukawa Y., Furukawa S., Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicology and Teratology 2002 24 5 695 701 2-s2.0-0036715390 10.1016/S0892-0362(02)00220-9 (Pubitemid 35013529)
16. Roghani M., Joghataie M. T., Jalali M. R., Baluchnejadmojarad T., Time course of changes in passive avoidance and Y-maze performance in male diabetic rats. Iranian Biomedical Journal 2006 10 2 99 104 2-s2.0-33645964967
17. Schmued L. C., Hopkins K. J., Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Research 2000 874 2 123 130 2-s2.0-0034714392 10.1016/S0006-8993(00)02513-0
18. Duch W., Therapeutic applications of computer models of brain activity for Alzheimer disease. Journal of Medical Informatics and Technologies 2000 5 27 34
19. Yan J.-J., Cho J.-Y., Kim H.-S., Kim K.-L., Jung J.-S., Huh S.-O., Suh H.-W., Kim Y.-H., Song D.-K., Protection against β -amyloid peptide toxicity in vivo with long-term administration of ferulic acid. British Journal of Pharmacology 2001 133 1 89 96 2-s2.0-0034986151 (Pubitemid 32500455)
20. Rasoolijazi H., Joghataie M. T., Roghani M., Nobakht M., The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iranian Biomedical Journal 2007 11 4 237 243 2-s2.0-35648943213 (Pubitemid 350021925)
21. Silva R. H., Abílio V. C., Takatsu A. L., Kameda S. R., Grassl C., Chehin A. B., Medrano W. A., Calzavara M. B., Registro S., Andersen M. L., Machado R. B., Carvalho R. C., Ribeiro R. D. A., Tufik S., Frussa-Filho R., Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 2004 46 6 895 903 2-s2.0-12144285674 10.1016/j.neuropharm.2003.11.032 (Pubitemid 38368922)
22. Erkan N., Ayranci G., Ayranci E., Antioxidant activities of rosemary (Rosmarinus Officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Food Chemistry 2008 110 1 76 82 2-s2.0-41549122728 10.1016/j.foodchem.2008.01.058
23. Svobodová A., Psotová J., Walterová D., Natural phenolics in the prevention of UV-induced skin damage. A review. Biomedical papers of the Medical Faculty of the University Palacký Olomouc, Czechoslovakia 2003 147 137 145
24. Poeckel D., Greiner C., Verhoff M., Rau O., Tausch L., Hörnig C., Steinhilber D., Schubert-Zsilavecz M., Werz O., Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochemical Pharmacology 2008 76 1 91 97 2-s2.0-45049087994 10.1016/j.bcp.2008.04.013
25. Kosaka K., Yokoi T., Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98g human glioblastoma cells. Biological and Pharmaceutical Bulletin 2003 26 11 1620 1622 2-s2.0-12744274953 10.1248/bpb.26.1620 (Pubitemid 41699648)
26. Ninomiya K., Matsuda H., Shimoda H., Nishida N., Kasajima N., Yoshino T., Morikawa T., Yoshikawa M., Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorganic and Medicinal Chemistry Letters 2004 14 8 1943 1946 2-s2.0-1642603546 10.1016/j.bmcl.2004.01.091 (Pubitemid 38410869)
27. Rezaie T., McKercher S. R., Kosaka K., Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration. Investigative Ophthalmology & Visual Science 2012 53 7847 7854